Medical tourism can be defined as an organized travel across international borders with the purpose of availing medical treatment of some form, which may or may not be available in the travelers' home country. The global medical tourism market accounted for $61,172 million in 2016, and is estimated to reach at $165,345 million by 2023, registering a CAGR of 15.0% from 2017 to 2023.
Medical tourists travel abroad for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities treatments available in other countries, which are comparatively expensive in their own country. It is also linked with leisure and business travel. Therefore, there are several definitions of medical tourism in the market. Some of them include cosmetic, dental, wellness, and spa services. However, for the purpose of this report, wellness, spa, cosmetic, and dental treatment are excluded from the scope of this study.
Availability of affordable medical care treatment in developing countries and growth in compliance on international standards drive the market. In addition, availability of latest medical treatments augment market growth. However, limited coverage and lengthy partial reimbursement by payers and epidemic outbreaks restrict the market. Furthermore, wider hospital network under insurance coverage for cashless transaction provides lucrative opportunities to the market players.
The medical tourism market is segmented based treatment type and geography. By treatment type, the market is divided into cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and other treatments. By geography, the market is analyzed across North America, Europe, AsiaPacific, and LAMEA.
This study provides a comprehensive overview of the competitive scenario of the market by profiling key market participants. The service providers profiled in this study include
KEY MARKET BENEFITS FOR STAKEHOLDERS
The study provides an indepth analysis of the global medical tourism market and the current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on application assists to understand the trends in the industry.
Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
KEY PLAYERS PROFILED IN THE REPORT
Apollo Hospitals Enterprise Ltd.
Fortis Healthcare Ltd.
Asian Heart Institute and Research Centre Pvt. Ltd.
KPJ Healthcare Berhad
Barbados Fertility Centre
NTT Medical Center Tokyo
Seoul National University Hospital
UZ Leuven University Hospitals Leuven
Infectious Diseases Partners Pte. Ltd.
Aditya Birla Memorial Hospital
Prince Court Medical Centre
Samitivej Public Company Limited;
KEY MARKET SEGMENTS
By Treatment Type
Cardiovascular Treatment
Orthopedic Treatment
Neurological Treatment
Cancer Treatment
Fertility Treatment
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
AsiaPacific
India
China
Indonesia
Singapore
Malaysia
Thailand
South Korea
Taiwan
Rest of AsiaPacific
LAMEA
Brazil
Venezuela
Costa Rica
UAE
South Africa
Rest of LAMEA
The other players in the value chain include profiles not included in the report
Bumrungrad International Hospital
MinSheng General Hospital
Raffles Medical Group
Bangkok Hospital Medical Center
NEXT ARTICLE